Choose-NI-metric: a shiny application for converting and comparing non-inferiority metrics in binary endpoint trials
Open Access
- 29 April 2026
- journal article
- software
- Published by Springer Nature in BMC Medical Research Methodology
- Vol. 26 (1)
Abstract
In non-inferiority (NI) clinical trials with binary outcomes, treatment effects are commonly quantified using the risk difference (RD), relative risk (RR),Keywords
Funding Information
- National Natural Science Foundation of China (82404374)
- National Natural Science Foundation of China (82273738)
- Qinglan Project of Jiangsu Province of China
This publication has 22 references indexed in Scilit:
- Risk difference, relative risk, and odds ratio for non-inferiority clinical trials with risk rate endpointJournal of Biopharmaceutical Statistics, 2022
- Non-immunogenic recombinant staphylokinase versus alteplase for patients with acute ischaemic stroke 4·5 h after symptom onset in Russia (FRIDA): a randomised, open label, multicentre, parallel-group, non-inferiority trialThe Lancet Neurology, 2021
- Non-inferiority testing for risk ratio, odds ratio and number needed to treat in three-arm trialComputational Statistics & Data Analysis, 2018
- How to Use a Noninferiority TrialJAMA, 2012
- Confidence intervals for odds ratio and relative risk based on the inverse hyperbolic sine transformationStatistics in Medicine, 2012
- A Mixed Approach for Proving Non‐Inferiority in Clinical Trials with Binary EndpointsBiometrical Journal, 2008
- Construction of confidence limits about effect measures: A general approachStatistics in Medicine, 2007
- Current issues in non‐inferiority trialsStatistics in Medicine, 2007
- Evidence‐Based Technical Analysis2006
- Design and analysis of non‐inferiority mortality trials in oncologyStatistics in Medicine, 2002